Bilimsel çalışmalar

Uzm. Dr. Kımıa Çepni

27 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. Effects of rectal retractor use on dosimetric parameters, treatment-related adverse events, and clinical outcomes of cervical cancer brachytherapy: A retrospective tertiary-centre study

    Clinical and Translational Radiation Oncology, 2026

    DOI 10.1016/j.ctro.2026.101302 PMID 42871204 Açık erişimli tam metinKaynak: OpenAlex

  2. Association of Pretreatment Hemoglobin and Lymphocyte Levels with Survival Outcomes in Cervical Cancer Patients Undergoing Chemoradiotherapy

    Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi, 2026

    DOI 10.38136/jgon.1967510 Açık erişimli tam metinKaynak: ORCID

  3. Impact of Response Rates on Overall Survival Following Chemoradiotherapy with or Without Surgery in Esophageal Cancer

    Cerrahpaşa Medical Journal, 2026

    DOI 10.5152/cjm.2026.25079 Açık erişimli tam metinKaynak: ORCID

  4. Efficacy and Safety of Radiotherapy in Head and Neck Paragangliomas: A Retrospective 23-Year Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15031062 PMID 41682742 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: ORCID

  5. Predictive Role of Pre-Radiotherapy D-Dimer and Inflammatory Markers in Monitoring Outcomes After Treatment in Hormone-Positive Breast Cancer: A Retrospective Cohort Study

    Diagnostics, 2026

    DOI 10.3390/diagnostics16040582 PMID 41750730 Açık erişimli tam metinKaynak: ORCID

  6. Pretreatment Neutrophil-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Esophageal Cancer Following Neoadjuvant Chemoradiotherapy

    Kasav international journal of health sciences., 2026

    DOI 10.29228/kijhs.95619 Kaynak: ORCID

  7. A multidimensional benchmarking framework for large language models in oncologic decision making

    Scientific Reports, 2026

    DOI 10.1038/s41598-026-61195-1 PMID 42481610 3 atıf (OpenAlex) Açık erişimli tam metinKaynak: OpenAlex

  8. Prognostic Significance of Lymphocyte Percentage and IL-6 Level in Patients Undergoing Radiotherapy for Advanced Lung Cancer

    Bezmialem Science, 2026

    DOI 10.14235/bas.galenos.2025.98624 Açık erişimli tam metinKaynak: OpenAlex

  9. Comparative validation of prognostic indices in brain metastases receiving cranial radiotherapy

    Oncology in Clinical Practice, 2025

    DOI 10.5603/ocp.108320 Açık erişimli tam metinKaynak: ORCID

  10. Prognostic value of D-dimer in treatment and follow up for patients who underwent radiotherapy in advanced lung cancer

    Plos One, 2025

    DOI 10.1371/journal.pone.0333085 PMID 40986549 Açık erişimli tam metinKaynak: ORCID

  11. Burnout Levels and Contributing Factors Among Radiation Oncology Resident Physicians

    Bezmialem Science, 2025

    DOI 10.14235/bas.galenos.2025.80090 Açık erişimli tam metinKaynak: OpenAlex

  12. Results of low dose helical arc intensive modulated radiotherapy (IMRT) in brain metastases localized in brainstem

    JOURNAL OF RADIATION ONCOLOGY AND PALLIATION, 2024

    DOI 10.29228/jrop.87999 Kaynak: OpenAlex

  13. Evaluation of Depression, Anxiety, and Sexual Function in Rectal Cancer Patients Before and After Neoadjuvant Chemoradiotherapy

    Journal of Gastrointestinal Cancer, 2023

    DOI 10.1007/s12029-023-00939-y PMID 37280447 3 atıf (OpenAlex) Kaynak: OpenAlex

  14. Selective local postoperative radiotherapy for T3–T4 N0 laryngeal cancer

    Strahlentherapie und Onkologie, 2022

    DOI 10.1007/s00066-022-01999-y PMID 36074137 5 atıf (Europe PMC) Kaynak: ORCID

  15. The investigation of fetal dose for mantle field irradiation of Hodgkin’s disease

    DOAJ (DOAJ: Directory of Open Access Journals), 2019

    DOI 10.2399/ctd.08.056 Kaynak: OpenAlex

  16. Comparison of changes in renal function with dosimetric parameters in gastric cancer patients treated with adjuvant chemoradiotherapy

    Japanese Journal of Radiology, 2017

    DOI 10.1007/s11604-017-0692-1 PMID 29064001 2 atıf (OpenAlex) Kaynak: OpenAlex

  17. Marginal zone lymphoma in the breast. A case report and review of the literature

    2016

    DOI 10.7353/polmed.2016.123.053 Kaynak: OpenAlex

  18. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması

    DergiPark (Istanbul University), 2014

    Açık erişimli tam metinKaynak: OpenAlex

  19. Randomized Trial of Oral Misoprostol Treatment for Cervical Ripening Before Tandem Application in Cervix Cancer

    International Journal of Radiation Oncology*Biology*Physics, 2011

    DOI 10.1016/j.ijrobp.2010.06.051 PMID 21377295 8 atıf (OpenAlex) Kaynak: OpenAlex

  20. The investigation of fetal doses in mantle field irradiation

    Radiation Protection Dosimetry, 2009

    DOI 10.1093/rpd/ncp034 PMID 19299479 4 atıf (OpenAlex) Kaynak: OpenAlex

  21. P-534 Results of high dose of gemcitabine + cisplatin combination in metastatic non-small cell lung cancer

    Lung Cancer, 2005

    DOI 10.1016/s0169-5002(05)81027-x Kaynak: OpenAlex

  22. 000204: RESULTS OF ADJUVANT BRACHYTHERAPY OF STAGE IB ENDOMETRIAL CARCINOMA

    International Journal of Gynecological Cancer, 2005

    DOI 10.1136/ijgc-00009577-200509001-00200 Açık erişimli tam metinKaynak: OpenAlex

  23. Tandem application with transvaginal ultrasound guidance

    International Journal of Radiation Oncology*Biology*Physics, 2004

    DOI 10.1016/j.ijrobp.2003.10.028 PMID 15093916 14 atıf (OpenAlex) Kaynak: OpenAlex

  24. Results of concurrent chemoradiotherapy with high-dose vinorelbine and amifostine in medically inoperable and stage IIIB NSCLC patients

    2004

    Kaynak: OpenAlex

  25. The consolidation study with docetaxel after combined chemoradiotherapy in Stage III B non-small cell lung carcinoma

    2004

    Kaynak: OpenAlex

  26. The 3-years survival results of concurrent chemoradiotherapy and vinorelbine in medically inoperable and Stage III B NSCLC patients

    2004

    Kaynak: OpenAlex

  27. Pilomatriks karsinoma: Olgu sunumu

    Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, 2003

    Kaynak: OpenAlex